Purchase Order 75F40126P00051
Award Date 6/23/26
Potential Completion Date 9/23/28
Potential Value $1.1M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
St. Louis, MO 63110, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Food and Drug Administration issued a purchase order to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business, for a quadrupole-orbitrap hybrid mass spectrometer, with a ceiling value of $593,655 and an award date of June 5, 2026. The order carries a total small business set-aside. Place of performance is Berwyn Heights, Maryland. Completion is due September 30, 2026.</p>
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB). The $1,092,204.46 contract is for the delivery of two mass spectrometers, with a completion date of September 22, 2027. Caitta Inc. is a strategic federal contractor focused on providing scientific instrumentation, analytical equipment, and professional services to...
- This is a $535,268.72 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB). The contract is for the delivery of a quadrupole-orbitrap high resolution mass spectrometer with liquid chromatograph. This specialized scientific instrumentation will support the FDA's analytical and regulatory missions. The contract has an ultimate completion date of October 17, 2026 and...
- The U.S. Food and Drug Administration (FDA) awarded a $780,589.47 firm-fixed-price purchase order contract to Caitta Inc., a certified economically disadvantaged woman-owned small business (EDWOSB), for the procurement of one liquid chromatography-high resolution mass spectrometer (LC-HRMS) system, including a data acquisition computer and software. This contract was set aside for total small business participation and has a performance period ending on February 22, 2027. Caitta Inc. is a...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB). The contract, valued at $711,271.48, is for the procurement of one Sciex Triple Quadrupole 7500 QTRAP mass spectrometer and preventative maintenance services for a base year and four 1-year option periods. This award was made under a total small business set-aside for the original solicitation, which sought...
- The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a firm fixed-price purchase order contract to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), for a new annual maintenance agreement for a SCIEX QTRAP 5500 LC-MS/MS system. The contract has a ceiling value of $168,262.56 and a completion date of February 19, 2029. Caitta Inc. is an experienced provider of scientific and technical services to federal agencies,...
- The Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), for the procurement of a Thermo Fisher Vanquish Neo Ultra-High-Performance Liquid Chromatography (UHPLC) system and an Easy-Spray Sources (ESI) kit. The $101,942.76 contract includes installation, testing, training, and warranty support. This award was made under a total small business set-aside solicitation for...
- Caitta Inc. was awarded a firm-fixed price purchase order totaling $627,786.88 by the Department of Health and Human Services' Food and Drug Administration to deliver one benchtop quadrupole-orbital trapping high-resolution mass spectrometer with liquid chromatograph. This award was made under a small business set-aside total small business solicitation seeking this type of analytical instrumentation to support research and development of qualitative and semi-quantitative methods for emerging...
- This is a $149,419.03 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for the procurement of an ultra-performance liquid chromatography (UPLC) system with a diode array detector (DAD), refrigerated sample compartment, auxiliary application programming interface (API) for a liquid chromatography-mass spectrometry (LC-MS)...
- This federal contract award was made by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), for the procurement of a Thermo Scientific AutoTrace 280 Solid Phase Extraction (SPE) System or equivalent instrument. The $80,523.76 firm fixed-price purchase order will support the FDA's nitrosamine testing program by automating the pre-concentration of contaminants from large-volume intravenous drug products. The...
The Food and Drug Administration awarded a purchase order to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), for a high-resolution mass spectrometry system on June 23, 2026, with a ceiling value of $1,100,220.26. The order carries a total small business set-aside designation. Performance will be completed by September 23, 2028, and the work is to be performed in St. Louis, Missouri. The purchase is firm fixed price.
Generated 6/27/26, 10:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0m | 6/22/26 |